血清1,5-脱水-D-山梨醇(1,5-AG)水平与心血管疾病风险的横断面研究

徐芊昊 ,  汪嘉辰 ,  付煜 ,  李悦 ,  杨涛

中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (6) : 782 -788.

PDF (3249KB)
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (6) : 782 -788. DOI: 10.12092/j.issn.1009-2501.2026.06.007

血清1,5-脱水-D-山梨醇(1,5-AG)水平与心血管疾病风险的横断面研究

作者信息 +

A cross-sectional study on the association between serum 1,5-anhydro-D-glucitol (1,5-AG) levels and cardiovascular disease risk

Author information +
文章历史 +
PDF (3326K)

摘要

目的: 评估血清 1,5-脱水-D-山梨醇(1,5-AG)水平与心血管疾病 (cardiovascular diseases,CVDs)发生发展风险的相关性,探讨其作为 CVDs 预测标志物的潜在价值。方法: 采用横断面研究设计,纳入江苏省南京市及句容市 873 名社区人群。通过化学酶发光法检测受试者血清 1,5-AG 水平,收集人口学特征、体格检查及实验室检查指标,构建多因素 Logistic 风险模型分析其与 CVDs 事件的关联,通过受试者工作特征曲线(ROC)及决策曲线分析(DCA)评估预测效能。结果: 829 名受试者(CVDs 组 166 人,对照组 663 人)纳入分析。CVDs 组血清 1,5-AG 水平显著低于对照组(0.11[0.08,0.14] μmol/Lvs. 0.12[0.09,0.16] μmol/L,P=0.003)。经多因素 Logistic 回归分析校正后,建立的模型提示低血清 1,5-AG 水平与 CVDs 风险增加有关(OR=0.011 1,P=0.039)。ROC 分析显示,整合血清 1,5-AG 与常规指标的预测模型,具有良好的 CVDs 风险判别效能(AUC=0.797),对应灵敏度为 0.681,特异度为 0.780,约登指数(Youden index)为 0.461。校正年龄和性别后,血清 1,5-AG 水平与 10 年心血管风险(r=−0.223)、出血性脑卒中(r=−0.260)和缺血性脑卒中(r=−0.274)均呈负相关,且P 值均小于 0.001。结论: 血清 1,5-AG 水平降低与 CVDs 风险独立相关,联合传统指标可提升预测效能,或为 CVDs 早期筛查提供新思路。

Abstract

AIM: To evaluate the association between serum 1,5-anhydro-D-glucitol (1,5-AG) levels and the risk of developing cardiovascular diseases (CVDs), and to explore its potential value as a predictive biomarker for CVDs. METHODS: A cross-sectional study design was adopted, enrolling 873 community residents from Nanjing and Jurong, Jiangsu Province. Serum 1,5-AG levels were measured using a chemiluminescence enzyme immunoassay. Demographic characteristics, physical examination data, and laboratory parameters were collected. Multivariate logistic risk models were constructed to analyze the association between 1,5-AG levels and CVD events. Predictive performance was evaluated using Receiver Operating Characteristic (ROC) curves and Decision Curve Analysis (DCA). RESULTS: A total of 829 subjects (166 in the CVDs group and 663 in the control group) were included in the final analysis. Serum 1,5-AG levels in the CVDs group were significantly lower than those in the control group (0.11[0.08, 0.14] μmol/Lvs. 0.12[0.09, 0.16] μmol/L,P = 0.003). After adjustment via multivariate logistic regression analysis, the established model indicated that low serum 1,5-AG levels were associated with an increased risk of CVDs (OR = 0.011 1, P = 0.039). ROC analysis showed that the predictive model integrating serum 1,5-AG with conventional indicators demonstrated good discriminative performance for CVD risk (AUC=0.797), with a sensitivity of 0.681, specificity of 0.780, and a Youden index of 0.461. After adjusting for age and sex, serum 1,5-AG levels were negatively correlated with 10-year cardiovascular risk (r=−0.223), hemorrhagic stroke (r=−0.260), and ischemic stroke (r=−0.274), with all P<0.001. CONCLUSION: Decreased serum 1,5-AG levels are independently associated with CVD risk. Combining 1,5-AG with traditional indicators can improve predictive performance, potentially providing a new perspective for early CVD screening.

关键词

1,5-AG / 心血管疾病 / 缺血性脑卒中 / 出血性脑卒中 / 疾病风险

Key words

1,5-anhydro-D-glucitol / cardiovascular disease / ischemic stroke / hemorrhagic stroke / disease risk

引用本文

引用格式 ▾
徐芊昊,汪嘉辰,付煜,李悦,杨涛. 血清1,5-脱水-D-山梨醇(1,5-AG)水平与心血管疾病风险的横断面研究[J]. 中国临床药理学与治疗学, 2026, 31(6): 782-788 DOI:10.12092/j.issn.1009-2501.2026.06.007

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Liu L, Wan X, Liu J, et al. Increased 1, 5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy[J].Diabetes Technol Ther, 2012, 14(9): 756-761.

[2]

INTERNATIONAL DIABETES FEDERATION GUIDELINE DEVELOPMENT Gx.Guideline for management of postmeal glucose in diabetes[J].Diabetes Res Clin Pract, 2014, 103(2): 256-268.

[3]

国家心血管病中心, 中国心血管健康与疾病报告编写组, 胡盛寿. 中国心血管健康与疾病报告 2023 概要[J].中国循环杂志, 2024, 39(7): 625-660.

[4]

Yamanouchi T, Shinohara T, Ogata N, et al. Common reabsorption system of 1, 5-anhydro-D-glucitol, fructose, and mannose in rat renal tubule[J].Biochim Biophys Acta, 1996, 1291(1): 89-95.

[5]

Wu Y, Liu X, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults[J].Circulation, 2006, 114(21): 2217-2225.

[6]

Yang S, Han Y, Yu C, et al. Development of a model to predict 10-year risk of ischemic and hemorrhagic stroke and ischemic heart disease using the China Kadoorie Biobank[J].Neurology, 2022, 98(23): e2307-e2317.

[7]

中华医学会糖尿病学分会. 中国糖尿病防治指南 (2024 版)[J].中华糖尿病杂志, 2025, 17(1): 136-139.

[8]

中华医学会心血管病学分会代谢性心血管疾病学组中. 心血管病合并糖代谢异常患者心血管风险综合管理中国专家共识[J].中华心血管病杂志, 2021, 49(7): 656-672.

[9]

Tong Y, Liu F, Huang K, et al. Changes in fasting blood glucose status and incidence of cardiovascular disease: the China-PAR project[J].J Diabetes, 2023, 15(2): 110-120.

[10]

Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis[J].BMJ, 2020, 370: m2297.

[11]

Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA)[J].Diabetologia, 2003, 46(9): 1190-1198.

[12]

Gyberg V, De Bacquer D, Kotseva K, et al. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV-a survey from the European Society of Cardiology[J].Eur Heart J, 2015, 36 (19): 1171-1177.

[13]

Yang ZJ, Liu J, Ge JP, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China national diabetes and metabolic disorders study[J].Eur Heart J, 2012, 33(2): 213-220.

[14]

Huang Y, Cai X, Mai W, et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis[J].BMJ, 2016, 355: i5953.

[15]

Zhou M, Liu J, Hao Y, et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the improving care for cardiovascular disease in China-acute coronary syndrome project[J].Cardiovasc Diabetol, 2018, 17(1): 147.

[16]

Ma X, Hao Y, Hu X, et al. 1, 5-anhydroglucitol is associated with early-phase insulin secretion in chinese patients with newly diagnosed type 2 diabetes mellitus[J].Diabetes Technol Ther, 2015, 17(5): 320-326.

[17]

Yamanouchi T, Akanuma Y.Serum 1, 5-anhydroglucitol (1, 5 AG): new clinical marker for glycemic control[J].Diabetes Res Clin Pract, 1994, 24 (Suppl 1): S261-S268.

[18]

Watanabe M, Yoshida K, Higashiyama A, et al. Serum 1, 5-anhydro-d-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study[J].Atherosclerosis, 2011, 216(2): 477-483.

[19]

韩志勇. 血清 1, 5-脱水葡萄糖醇的临床应用研究进展[J].实用检验医师杂志, 2015, 7(1): 47-50.

[20]

吴学毅, 邵丽娟, 田嘉嘉. 1, 5 -脱水葡萄糖醇在糖尿病管理中的应用[J].中华糖尿病杂志, 2022, 14(增刊): 19-22.

基金资助

江苏省自然科学基金(BK20220721)

AI Summary AI Mindmap
PDF (3249KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉